Ken McBean has served as President since joining the company in September 2011. In March 2014, the Board of Directors of Chiesi S.p.A. appointed Mr. McBean to Chiesi’s Group Executive Committee and to the Board of Directors of Chiesi USA, Inc. In May 2014, Mr. McBean was also appointed Chief Executive Officer of Chiesi USA, Inc.
Joshua B. Franklin has served as Senior Vice President, Marketing and Corporate Development since November 2015. Since joining the company in 2008, Mr. Franklin has served in a number of senior Marketing, Corporate Strategy and Business Development roles. Prior to joining the company, Mr. Franklin was Vice President, Marketing for Ther-Rx Corporation. In addition, Mr. Franklin held various marketing roles at Biovail and the Ross Products Division of Abbott Laboratories.
Mr. Franklin is a United States Army veteran. He holds a Masters of Business Administration and a Masters of Health Administration from the Ohio State University and a Bachelor of Science in Business Administration from Methodist University.
Alan T. Roberts has served as Senior Vice President, Scientific Affairs/Compliance Officer since November 2015. Mr. Roberts joined the company as Vice President, Scientific Affairs in 2009. Prior to joining the company, Mr. Roberts founded Tybeam Pharma Consulting, LLC and served as its President. Previously, Mr. Roberts served as Senior Vice President and Chief Scientific Officer for Auriga Laboratories, Inc. Mr. Roberts also held various leadership positions at First Horizon Pharmaceutical Corporation and Mikart. In addition, Mr. Roberts held key management positions in regulatory and development at Solvay Pharmaceuticals, Inc.
Mr. Roberts holds a Bachelor of Science in Microbiology from Clemson University.
Jon Zwinski has served as Senior Vice President, Sales since November 2015. Mr. Zwinski joined the company as Vice President, Sales in July 2012. Previously Mr. Zwinski served as Vice President of Sales at EKR Therapeutics. Since starting his career at Organon Pharmaceuticals in 1994, Mr. Zwinski has worked in many sales and national account roles beginning at the field level and progressing through field leadership to senior-level leadership roles. Mr. Zwinski has broad experience across many therapeutic areas including anesthesia, women’s health, emergency medicine, psychiatry, neurology, neonatology, urology and cystic fibrosis. Throughout his career, Mr. Zwinski has led successful contracting and pull-through strategies with customers at the Managed Care, Trade, GPO, Hospital IDN, Hospital, and Specialty Pharmacy levels.
Mr. Zwinski earned a Bachelor of Science in Education from Bowling Green State University.
Amy Diebler has served as the company’s Vice President, Finance and Chief Financial Officer since March 2014. Prior to that, Ms. Diebler served as Senior Director, Corporate Finance and Development from July 2012 to March 2014, and Director, Financial Reporting from June 2009 to July 2012. Before joining the company, Ms. Diebler was a senior assurance manager at Ernst & Young LLP.
Ms. Diebler holds a B.B.A. in Accounting and Masters of Accountancy from Stetson University.
Michael R. Gordon joined the company as Vice President, Legal Affairs and General Counsel in 2014. Prior to joining the company, Mr. Gordon practiced law for almost twenty years. He began his career as an Assistant District Attorney in New York City in the Manhattan District Attorney’s Office under the Honorable Robert M. Morgenthau. Mr. Gordon also served as an associate and partner at the Raleigh, North Carolina law firm of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP. Most recently, Mr. Gordon was a partner in the Research Triangle Park, North Carolina office of the international law firm of K&L Gates, LLP.
Mr. Gordon is admitted to the North Carolina and New York state bar. He earned a J.D. from Brooklyn Law School and a B.A. from Tulane University.